INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 85 filers reported holding INARI MED INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,939,613 | +5.9% | 656,569 | -5.9% | 0.01% | 0.0% |
| Q2 2023 | $40,561,313 | +4.2% | 697,649 | +10.6% | 0.01% | 0.0% |
| Q1 2023 | $38,932,998 | -9.8% | 630,596 | -7.1% | 0.01% | -11.1% |
| Q4 2022 | $43,160,227 | -12.4% | 679,047 | +0.2% | 0.01% | -18.2% |
| Q3 2022 | $49,252,000 | +16.7% | 678,028 | +9.2% | 0.01% | +22.2% |
| Q2 2022 | $42,212,000 | +20.5% | 620,845 | +60.7% | 0.01% | +50.0% |
| Q1 2022 | $35,026,000 | +12.1% | 386,430 | +12.9% | 0.01% | +20.0% |
| Q4 2021 | $31,247,000 | +13.1% | 342,364 | +0.5% | 0.01% | 0.0% |
| Q3 2021 | $27,629,000 | -1.3% | 340,668 | +13.6% | 0.01% | 0.0% |
| Q2 2021 | $27,981,000 | +52.1% | 299,975 | +74.5% | 0.01% | +66.7% |
| Q1 2021 | $18,398,000 | +107.8% | 171,937 | +69.5% | 0.00% | +50.0% |
| Q4 2020 | $8,853,000 | +25.7% | 101,413 | -0.6% | 0.00% | 0.0% |
| Q3 2020 | $7,044,000 | +730.7% | 102,052 | +483.3% | 0.00% | – |
| Q2 2020 | $848,000 | – | 17,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,426,584 | $115,696,000 | 3.81% |
| Affinity Asset Advisors, LLC | 135,000 | $10,949,000 | 2.76% |
| SECTORAL ASSET MANAGEMENT INC | 289,650 | $23,491,000 | 1.95% |
| Pier Capital, LLC | 99,434 | $8,064,000 | 0.84% |
| Beck Bode, LLC | 27,853 | $2,259,000 | 0.63% |
| CNA FINANCIAL CORP | 22,993 | $1,865,000 | 0.51% |
| NEXT CENTURY GROWTH INVESTORS LLC | 59,245 | $4,804,000 | 0.42% |
| Birchview Capital, LP | 7,000 | $568,000 | 0.39% |
| PDT Partners, LLC | 59,849 | $4,854,000 | 0.35% |
| HAMILTON LANE ADVISORS LLC | 24,900 | $2,019,000 | 0.34% |